| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
taperin | 0.839 | 0.115 | 7.2E-03 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
glutaredoxin and cysteine rich domain containing 1 | 0.861 | 0.115 | 3.9E-11 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
pejvakin | 0.769 | 0.115 | 3.7E-08 |
|
phenotype | 0.420 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
transmembrane inner ear | 0.890 | 0.115 | 7.7E-05 |
|
phenotype | 0.410 | strong | < 0.001 | 0 | 0 | 2006 | 2006 | ||||||||
|
leucine rich transmembrane and O-methyltransferase domain containing | 0.792 | 0.192 | 7.0E-05 |
|
phenotype | 0.430 | strong | 1.000 | 1 | 0 | 2007 | 2012 | ||||||||
|
lipoxygenase homology domains 1 | 0.792 | 0.231 | 5.6E-26 |
|
phenotype | 0.320 | strong | 0.667 | 1 | 0 | 2012 | 2018 | ||||||||
|
GIPC PDZ domain containing family member 3 | 0.780 | 0.231 | 9.3E-03 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
TRIO and F-actin binding protein | 0.743 | 0.269 | 2.0E-28 |
|
phenotype | 0.430 | strong | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
myosin IIIA | 0.780 | 0.269 | 1.8E-45 |
|
phenotype | 0.410 | strong | 1.000 | 1 | 0 | 2011 | 2016 | ||||||||
|
myosin IA | 0.769 | 0.269 | 8.9E-46 |
|
phenotype | 0.300 | limited | 0 | 0 | |||||||||||
|
methionine sulfoxide reductase B3 | 0.729 | 0.308 | 3.8E-03 |
|
phenotype | 0.600 | strong | 1.000 | 1 | 0 | 2011 | 2014 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
transmembrane channel like 1 | 0.769 | 0.346 | 9.2E-19 |
|
phenotype | 0.450 | strong | 0.833 | 1 | 0 | 2004 | 2015 | ||||||||
|
USH1 protein network component sans | 0.659 | 0.346 | 3.7E-05 |
|
phenotype | 0.620 | strong | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
crystallin mu | 0.769 | 0.346 | 2.6E-02 |
|
phenotype | 0.310 | limited | 1.000 | 1 | 0 | 1997 | 2003 | ||||||||
|
immunoglobulin like domain containing receptor 1 | 0.729 | 0.346 | 2.6E-12 |
|
phenotype | 0.420 | strong | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
myosin XVA | 0.722 | 0.346 | 1.3E-56 |
|
phenotype | 0.430 | strong | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
ATPase H+ transporting V1 subunit B1 | 0.695 | 0.346 | 2.4E-09 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
cochlin | 0.659 | 0.385 | 1.2E-07 |
|
phenotype | 0.400 | strong | 0.909 | 1 | 0 | 1999 | 2019 | ||||||||
|
whirlin | 0.670 | 0.385 | 7.7E-05 |
|
phenotype | 0.430 | strong | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
abhydrolase domain containing 12 | 0.666 | 0.385 | 1.9E-05 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
MN1 proto-oncogene, transcriptional regulator | 0.682 | 0.385 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
tectorin alpha | 0.700 | 0.385 | 3.0E-16 |
|
phenotype | 0.500 | strong | 1.000 | 1 | 0 | 1998 | 2018 | ||||||||
|
otoferlin | 0.691 | 0.385 | 5.4E-39 |
|
phenotype | 0.480 | strong | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
otoancorin | 0.760 | 0.423 | 3.0E-10 |
|
phenotype | 0.310 | strong | 1.000 | 1 | 0 | 2012 | 2013 |